Smart & Biggar partner David Schwartz to present at the 2nd Annual IAM Pharma & Biotech IP Summit
February 2, 2018

Smart & Biggar is proud to sponsor the 2nd Annual IAM Pharma and Biotech IP Summit in London, UK on February 8th, 2018. 

Firm partner David Schwartz will be attending the event to discuss the latest strategies for IP success, and to network and engage with like-minded IP professionals.

David Schwartz

David Schwartz will be moderating and participating in a panel titled Supplementary Protection Certificates – patent extensions in Europe. This session will look at the potential changes and impact of the supplementary protection certificate referrals to the European Court of Justice (ECJ) coinciding with the European Commission’s incentives review. David, along with industry experts Fiona Bar and Andrew Cook, will discuss the recent ECJ referrals and their consequences, asses the European Commission’s review and likely outcomes, and examine how IP strategies will need to adapt.

The second annual Pharma and Biotech IP Summit will bring together leading IP experts from across life sciences. Attendees will hear the latest IP strategies for thriving at a time when regulatory and legislative changes are significantly impacting business models.


Smart & Biggar is Canada's largest firm practising exclusively in intellectual property and technology law, with offices in Ottawa, Toronto, Montreal, Vancouver and Calgary. As leaders in intellectual property and technology law Smart & Biggar has been serving clients for over a century. For more information, please visit

web design toronto Rebel Trail